{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:58:03Z","timestamp":1790737083121,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473610"],"award-info":[{"award-number":["81473610"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973785"],"award-info":[{"award-number":["81973785"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.biopha.2020.110286","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T17:40:52Z","timestamp":1591551652000},"page":"110286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-\u03baB pathway"],"prefix":"10.1016","volume":"128","author":[{"given":"Manman","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuhua","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2020.110286_bib0005","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology."},{"issue":"7","key":"10.1016\/j.biopha.2020.110286_bib0015","first-page":"85","article-title":"Nonalcoholic fatty liver disease: diagnostic, symptoms, treatment. Guidelines were approved by the xv gastroenterological scientific society of Russia in 2015","author":"Lazebnik","year":"2015","journal-title":"Eksp Klin Gastroenterol"},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"issue":"3","key":"10.1016\/j.biopha.2020.110286_bib0025","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/ijms17030376","article-title":"Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease","volume":"17","author":"Ban","year":"2016","journal-title":"Int J Mol Sci."},{"issue":"4","key":"10.1016\/j.biopha.2020.110286_bib0030","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology."},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12944-017-0572-9","article-title":"A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease","volume":"16","author":"Chen","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","article-title":"Recent insights into the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"Arab","year":"2018","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2020.110286_bib0045","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1210\/en.2016-1582","article-title":"Liver NF-\u03baB-Inducing Kinase Promotes Liver Steatosis and Glucose Counterregulation in Male Mice With Obesity","volume":"158","author":"Liu","year":"2017","journal-title":"Endocrinology."},{"issue":"10","key":"10.1016\/j.biopha.2020.110286_bib0050","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.cellsig.2015.07.011","article-title":"SREBP-1c overactivates ROS-mediated hepatic NF-\u03baB inflammatory pathway in dairy cows with fatty liver","volume":"27","author":"Li","year":"2015","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","article-title":"Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1, and NF-kappa B pathways","volume":"53","author":"Xiao","year":"2014","journal-title":"Eur. J. Nutr."},{"issue":"2","key":"10.1016\/j.biopha.2020.110286_bib0060","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yexmp.2014.07.001","article-title":"TLR3\/4 signaling is mediated via the NF\u03baB-CXCR4\/7 pathway in human alcoholic hepatitis and non-alcoholic steatohepatitis which formed Mallory-Denk bodies","volume":"97","author":"Liu","year":"2014","journal-title":"Exp. Mol. Pathol."},{"issue":"1-3","key":"10.1016\/j.biopha.2020.110286_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12026-008-8025-1","article-title":"The IkappaB kinase complex: master regulator of NF-kappaB signaling","volume":"42","author":"Solt","year":"2018","journal-title":"Immunol Res."},{"key":"10.1016\/j.biopha.2020.110286_bib0070","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.biopha.2018.04.057","article-title":"Anaphylatoxin C5a induces inflammation and reduces insulin sensitivity by activating TLR4\/NF-kB\/PI3K signaling pathway in 3T3-L1 adipocytes","volume":"103","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"39","key":"10.1016\/j.biopha.2020.110286_bib0075","doi-asserted-by":"crossref","first-page":"14205","DOI":"10.3748\/wjg.v20.i39.14205","article-title":"Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease","volume":"20","author":"Paradies","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"29","key":"10.1016\/j.biopha.2020.110286_bib0080","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.2174\/1381612811319290011","article-title":"Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target","volume":"19","author":"Miele","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"19","key":"10.1016\/j.biopha.2020.110286_bib0085","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.3748\/wjg.v21.i19.5877","article-title":"Effect of nuclear factor-\u03baB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease","volume":"21","author":"Tan","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0090","first-page":"28","article-title":"Experimental study on anti-duck hepatitis B virus with 919 syrup","volume":"12","author":"Huang","year":"2002","journal-title":"Chinese journal of integrated traditional and western medicine on liver diseases."},{"issue":"3","key":"10.1016\/j.biopha.2020.110286_bib0095","first-page":"160","article-title":"Experimental study of 919 syrup anti-hepatic fibrosis in rats","volume":"13","author":"Huang","year":"2003","journal-title":"Chinese journal of integrated traditional and western medicine on liver diseases."},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0100","first-page":"17","article-title":"Clinical study of 919 syrup in the treatment of chronic hepatitis B","volume":"10","author":"Jun","year":"1995","journal-title":"China Journal of Traditional Chinese Medicine and Pharmacy. 1995"},{"issue":"5","key":"10.1016\/j.biopha.2020.110286_bib0105","first-page":"53","article-title":"Experimental Study on 919 Syrup in Protecting Liver","volume":"39","author":"Gao","year":"2005","journal-title":"Shanghai Journal of Traditional Chinese Medicine."},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0110","first-page":"1217","article-title":"Effects of 919 syrup and D101 on immobilization stress response in postpartum mice","volume":"12","author":"Chen","year":"2019","journal-title":"Int J Clin Exp Med."},{"key":"10.1016\/j.biopha.2020.110286_bib0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2020.110286_bib0120","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cld.2012.03.005","article-title":"Nonalcoholic Fatty Liver Disease","volume":"16","author":"Paredes","year":"2012","journal-title":"Clin Liver Dis."},{"key":"10.1016\/j.biopha.2020.110286_bib0125","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopha.2018.06.134","article-title":"Protective effects of Kangxian ruangan capsule against nonalcoholic fatty liver disease fibrosis in rats induced by MCD diet","volume":"108","author":"Liu","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.biopha.2020.110286_bib0130","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3389\/fphar.2018.01459","article-title":"Herbal Extracts and Natural Products in Alleviating Non-alcoholic Fatty Liver Disease via Activating Autophagy","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110286_bib0135","first-page":"6527","article-title":"Effects of the chinese herbal medicine mixture 919 syrup on the isolation stress response in postpartum mice","volume":"10","author":"Xu","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.biopha.2020.110286_bib0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-9422(02)00513-7","article-title":"Rosmarinic acid","volume":"62","author":"Petersen","year":"2003","journal-title":"Phytochemistry."},{"issue":"10","key":"10.1016\/j.biopha.2020.110286_bib0145","first-page":"694","article-title":"Studies on chemical constituents of Schisandra propinqua (wall.) hook. f. et thoms","volume":"26","author":"Chen","year":"2001","journal-title":"China Journal of Chinese Materia Medica."},{"key":"10.1016\/j.biopha.2020.110286_bib0150","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.biopha.2018.11.069","article-title":"Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development","volume":"110","author":"Chen","year":"2019","journal-title":"Biomed Pharmacother."},{"key":"10.1016\/j.biopha.2020.110286_bib0155","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nutres.2019.01.001","article-title":"Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet","volume":"64","author":"Jeong","year":"2019","journal-title":"Nutr Res."},{"key":"10.1016\/j.biopha.2020.110286_bib0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbi.2014.02.003","article-title":"Protective effects of neohesperidin dihydrochalcone against carbon tetrachloride-induced oxidative damage in vivo and in vitro","volume":"213","author":"Hu","year":"2014","journal-title":"Chem. Biol. Interact."},{"issue":"8","key":"10.1016\/j.biopha.2020.110286_bib0165","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1440-1681.2007.04636.x","article-title":"Narirutin inhibits airway inflammation in an allergic mouse model","volume":"34","author":"Funaguchi","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110286_bib0170","doi-asserted-by":"crossref","first-page":"pii: E648","DOI":"10.3390\/nu11030648","article-title":"Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4\/NF-\u03baB signaling","volume":"11","author":"Muhammad","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2020.110286_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2016.12.010","article-title":"Salvianolic acid B protects against chronic alcoholic liver injury via SIRT1-mediated inhibition of CRP and ChREBP in rats","volume":"267","author":"Zhang","year":"2017","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0180","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.intimp.2015.08.003","article-title":"Blockade of TNF-\u03b1-induced NF-\u03baB signaling pathway and anti-cancer therapeutic response of dihydrotanshinone I","volume":"28","author":"Wang","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110286_bib0185","first-page":"4639","article-title":"Effect of tanshinone IIA on oxidative stress and apoptosis in a rat model of fatty liver","volume":"14","author":"Yang","year":"2017","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.biopha.2020.110286_bib0190","first-page":"248","article-title":"Cryptotanshinone inhibits oxidized LDL-induced adhesion molecule expression via ROS dependent NF-\u03baB pathways, Cell Adh","volume":"10","author":"Zhao","year":"2016","journal-title":"Migr."},{"issue":"3","key":"10.1016\/j.biopha.2020.110286_bib0195","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1590\/s0004-2803.201900000-51","article-title":"A study of metabolic parameters in non diabetic patients with non-alcoholic fatty liver disease - importance of dyslipidemia","volume":"56","author":"Ray","year":"2019","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.biopha.2020.110286_bib0200","doi-asserted-by":"crossref","DOI":"10.1097\/00004836-200609000-00016","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: Metabolic significance of nonalcoholic fatty liver disease in nonobese adults","author":"Chen","year":"2006","journal-title":"J. Clin. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110286_bib0205","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1159\/000375353","article-title":"Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH","volume":"33","author":"Traussnigg","year":"2015","journal-title":"Dig. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2020.110286_bib0210","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/dom.13007","article-title":"Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial","volume":"19","author":"Khoo","year":"2017","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2020.110286_bib0215","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1172\/JCI119247","article-title":"Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells","volume":"99","author":"Shimomura","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.biopha.2020.110286_bib0220","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","article-title":"SREBPs: Metabolic integrators in physiology and metabolism","volume":"23","author":"Jeon","year":"2012","journal-title":"Trends Endocrinol Metab."},{"issue":"7","key":"10.1016\/j.biopha.2020.110286_bib0225","doi-asserted-by":"crossref","first-page":"e38346","DOI":"10.5812\/hepatmon.38346","article-title":"Fibroscan Compared to FIB-4, APRI, and AST\/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease","volume":"16","author":"Fallatah","year":"2016","journal-title":"Hepat Mon."},{"issue":"86-87","key":"10.1016\/j.biopha.2020.110286_bib0230","first-page":"1681","article-title":"Albumin and prealbumin may predict retinol status in patients with liver cirrhosis","volume":"55","author":"Chang","year":"2008","journal-title":"Hepatogastroenterology"},{"issue":"5","key":"10.1016\/j.biopha.2020.110286_bib0235","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1665-2681(19)31247-5","article-title":"Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease","volume":"13","author":"Wenfeng","year":"2014","journal-title":"Ann Hepatol."},{"key":"10.1016\/j.biopha.2020.110286_bib0240","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","article-title":"Function and Activation of NF-kappaB in the Immune System","volume":"12","author":"Baeuerle","year":"1994","journal-title":"Annu Rev Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.15407\/fz58.01.093","article-title":"NF-kB activation as a molecular basis of pathological process by metabolic syndrome","volume":"58","author":"Ka\u01d0dashev","year":"2012","journal-title":"Fiziol Zh."},{"issue":"2","key":"10.1016\/j.biopha.2020.110286_bib0250","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.hepres.2005.09.020","article-title":"Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases","volume":"33","author":"Seki","year":"2005","journal-title":"Hepatol Res."},{"issue":"5412","key":"10.1016\/j.biopha.2020.110286_bib0255","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.284.5412.321","article-title":"Severe liver degeneration in mice lacking the IkappaB kinase 2 gene","volume":"284","author":"Li","year":"1999","journal-title":"Science."},{"issue":"2","key":"10.1016\/j.biopha.2020.110286_bib0260","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1194\/jlr.M300396-JLR200","article-title":"Dietary \u03b1-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells","volume":"45","author":"Vecchini","year":"2004","journal-title":"J. Lipid Res."},{"issue":"6","key":"10.1016\/j.biopha.2020.110286_bib0265","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/jhep.2001.29628","article-title":"Gene expression of tumor necrosis factor \u03b1 and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients","volume":"34","author":"Crespo","year":"2001","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.biopha.2020.110286_bib0270","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1111\/jcmm.13787","article-title":"CXCL6-EGFR-induced kupffer cells secrete TGF-\u03b21 promoting hepatic stellate cell activation via the SMAD2\/BRD4\/C-MYC\/ EZH2 pathway in liver fibrosis","volume":"22","author":"Cai","year":"2018","journal-title":"J Cell Mol Med."},{"issue":"3","key":"10.1016\/j.biopha.2020.110286_bib0275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1139\/bcb-2015-0136","article-title":"CXCL6 promotes human hepatocyte proliferation through the CXCR1-NF\u03baB pathway and inhibits collagen i secretion by hepatic stellate cells","volume":"94","author":"Li","year":"2016","journal-title":"Biochem Cell Biol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.LAB.0000048719.53282.00","article-title":"The CXC chemokine GCP-2\/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1\u03b2 and is down-regulated by interferon-\u03b3: Comparison with interleukin-8\/CXCL8","volume":"83","author":"Wuyts","year":"2003","journal-title":"Lab Invest."},{"issue":"1","key":"10.1016\/j.biopha.2020.110286_bib0285","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ni1018","article-title":"Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shutting of PPAR-\u03b3 and ReIA","volume":"5","author":"Kelly","year":"2004","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110286_bib0290","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2567.2008.02849.x","article-title":"Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor \u03b3 and nuclear factor-\u03baB in macrophages","volume":"125","author":"Necela","year":"2008","journal-title":"Immunology."},{"issue":"10","key":"10.1016\/j.biopha.2020.110286_bib0295","doi-asserted-by":"crossref","first-page":"e78051","DOI":"10.1371\/journal.pone.0078051","article-title":"Bupleurum Polysaccharides Attenuates Lipopolysaccharide-Induced Inflammation via Modulating Toll-Like Receptor 4 Signaling","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220304789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220304789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:41:21Z","timestamp":1777689681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220304789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":59,"alternative-id":["S0753332220304789"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110286","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-\u03baB pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110286"}}